Annual Long Term Debt
$38.18 B
+$1.87 B+5.14%
31 December 2023
Summary:
Bristol-Myers Squibb annual long term debt is currently $38.18 billion, with the most recent change of +$1.87 billion (+5.14%) on 31 December 2023. During the last 3 years, it has fallen by -$10.99 billion (-22.34%). BMY annual long term debt is now -22.34% below its all-time high of $49.17 billion, reached on 31 December 2020.BMY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$50.16 B
-$139.00 M-0.28%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly long term debt is currently $50.16 billion, with the most recent change of -$139.00 million (-0.28%) on 30 September 2024. Over the past year, it has increased by +$16.51 billion (+49.05%). BMY quarterly long term debt is now -1.75% below its all-time high of $51.05 billion, reached on 31 March 2024.BMY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.1% | +49.0% |
| 3 y3 years | -22.3% | +23.5% |
| 5 y5 years | +576.3% | +105.7% |
BMY Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.3% | +5.1% | -1.8% | +49.0% |
| 5 y | 5 years | -22.3% | +576.3% | -1.8% | +105.7% |
| alltime | all time | -22.3% | >+9999.0% | -1.8% | >+9999.0% |
Bristol-Myers Squibb Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.16 B(-0.3%) |
| June 2024 | - | $50.30 B(-1.5%) |
| Mar 2024 | - | $51.05 B(+33.7%) |
| Dec 2023 | $38.18 B(+5.1%) | $38.18 B(+13.5%) |
| Sept 2023 | - | $33.65 B(-6.5%) |
| June 2023 | - | $36.00 B(-1.2%) |
| Mar 2023 | - | $36.45 B(+0.4%) |
| Dec 2022 | $36.32 B(-10.3%) | $36.32 B(-4.0%) |
| Sept 2022 | - | $37.81 B(-0.3%) |
| June 2022 | - | $37.92 B(-1.0%) |
| Mar 2022 | - | $38.30 B(-5.4%) |
| Dec 2021 | $40.48 B(-17.7%) | $40.48 B(-0.3%) |
| Sept 2021 | - | $40.61 B(-6.6%) |
| June 2021 | - | $43.47 B(-4.1%) |
| Mar 2021 | - | $45.33 B(-7.8%) |
| Dec 2020 | $49.17 B(+11.6%) | $49.17 B(+16.8%) |
| Sept 2020 | - | $42.09 B(-1.1%) |
| June 2020 | - | $42.56 B(-2.2%) |
| Mar 2020 | - | $43.53 B(-1.2%) |
| Dec 2019 | $44.06 B(+680.4%) | $44.06 B(+80.6%) |
| Sept 2019 | - | $24.39 B(-0.2%) |
| June 2019 | - | $24.43 B(+333.6%) |
| Mar 2019 | - | $5.63 B(-0.2%) |
| Dec 2018 | $5.65 B(-19.1%) | $5.65 B(-0.7%) |
| Sept 2018 | - | $5.69 B(+0.3%) |
| June 2018 | - | $5.67 B(-1.8%) |
| Mar 2018 | - | $5.78 B(-17.2%) |
| Dec 2017 | $6.97 B(+22.0%) | $6.97 B(-0.1%) |
| Sept 2017 | - | $6.98 B(+1.0%) |
| June 2017 | - | $6.91 B(-4.5%) |
| Mar 2017 | - | $7.24 B(+26.6%) |
| Dec 2016 | $5.72 B(-12.7%) | $5.72 B(-2.1%) |
| Sept 2016 | - | $5.84 B(-11.3%) |
| June 2016 | - | $6.58 B(-0.2%) |
| Mar 2016 | - | $6.59 B(+0.7%) |
| Dec 2015 | $6.55 B(-9.6%) | $6.55 B(-1.2%) |
| Sept 2015 | - | $6.63 B(+0.3%) |
| June 2015 | - | $6.62 B(-7.2%) |
| Mar 2015 | - | $7.13 B(-1.6%) |
| Dec 2014 | $7.24 B(-9.3%) | $7.24 B(-0.3%) |
| Sept 2014 | - | $7.27 B(-1.4%) |
| June 2014 | - | $7.37 B(+0.1%) |
| Mar 2014 | - | $7.37 B(-7.7%) |
| Dec 2013 | $7.98 B(+21.5%) | $7.98 B(+22.2%) |
| Sept 2013 | - | $6.53 B(+1.4%) |
| June 2013 | - | $6.44 B(-1.2%) |
| Mar 2013 | - | $6.52 B(-0.7%) |
| Dec 2012 | $6.57 B(+22.2%) | $6.57 B(-0.6%) |
| Sept 2012 | - | $6.61 B(+26.9%) |
| June 2012 | - | $5.21 B(-1.2%) |
| Mar 2012 | - | $5.27 B(-2.0%) |
| Dec 2011 | $5.38 B(+0.9%) | $5.38 B(-1.1%) |
| Sept 2011 | - | $5.44 B(+2.0%) |
| June 2011 | - | $5.33 B(+1.1%) |
| Mar 2011 | - | $5.28 B(-1.0%) |
| Dec 2010 | $5.33 B(-13.1%) | $5.33 B(-14.7%) |
| June 2010 | - | $6.25 B(+2.7%) |
| Mar 2010 | - | $6.08 B(-0.8%) |
| Dec 2009 | $6.13 B(-6.9%) | $6.13 B(-2.8%) |
| Sept 2009 | - | $6.31 B(+1.2%) |
| June 2009 | - | $6.24 B(-4.0%) |
| Mar 2009 | - | $6.49 B(-1.4%) |
| Dec 2008 | $6.58 B(+50.3%) | $6.58 B(+7.6%) |
| Sept 2008 | - | $6.12 B(+1.6%) |
| June 2008 | - | $6.02 B(+29.2%) |
| Mar 2008 | - | $4.66 B(+6.4%) |
| Dec 2007 | $4.38 B(-39.6%) | $4.38 B(+3.1%) |
| Sept 2007 | - | $4.25 B(-39.1%) |
| June 2007 | - | $6.98 B(-2.2%) |
| Mar 2007 | - | $7.13 B(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $7.25 B(-13.3%) | $7.25 B(-7.5%) |
| Sept 2006 | - | $7.84 B(-4.9%) |
| June 2006 | - | $8.24 B(-0.5%) |
| Mar 2006 | - | $8.28 B(-1.0%) |
| Dec 2005 | $8.36 B(-1.2%) | $8.36 B(+41.9%) |
| Sept 2005 | - | $5.89 B(-1.9%) |
| June 2005 | - | $6.01 B(-27.8%) |
| Mar 2005 | - | $8.33 B(-1.6%) |
| Dec 2004 | $8.46 B(-0.7%) | $8.46 B(-0.9%) |
| Sept 2004 | - | $8.54 B(+2.0%) |
| June 2004 | - | $8.38 B(-3.0%) |
| Mar 2004 | - | $8.63 B(+1.3%) |
| Dec 2003 | $8.52 B(+36.1%) | $8.52 B(+14.8%) |
| Sept 2003 | - | $7.42 B(+15.6%) |
| June 2003 | - | $6.42 B(+0.9%) |
| Mar 2003 | - | $6.37 B(+1.7%) |
| Dec 2002 | $6.26 B(+0.4%) | $6.26 B(+0.9%) |
| Sept 2002 | - | $6.20 B(+1.0%) |
| June 2002 | - | $6.14 B(-0.5%) |
| Mar 2002 | - | $6.17 B(-1.1%) |
| Dec 2001 | $6.24 B(+366.8%) | $6.24 B(-0.4%) |
| Sept 2001 | - | $6.26 B(+380.7%) |
| June 2001 | - | $1.30 B(-1.1%) |
| Mar 2001 | - | $1.32 B(-1.5%) |
| Dec 2000 | $1.34 B(-0.4%) | $1.34 B(+1.0%) |
| Sept 2000 | - | $1.32 B(-0.5%) |
| June 2000 | - | $1.33 B(-0.2%) |
| Mar 2000 | - | $1.33 B(-0.7%) |
| Dec 1999 | $1.34 B(-1.6%) | $1.34 B(+0.8%) |
| Sept 1999 | - | $1.33 B(+0.3%) |
| June 1999 | - | $1.33 B(-3.1%) |
| Mar 1999 | - | $1.37 B(+0.4%) |
| Dec 1998 | $1.36 B(+6.6%) | $1.36 B(+3.8%) |
| Sept 1998 | - | $1.31 B(-1.6%) |
| June 1998 | - | $1.34 B(-3.7%) |
| Mar 1998 | - | $1.39 B(+8.4%) |
| Dec 1997 | $1.28 B(+32.4%) | $1.28 B(+1.1%) |
| Sept 1997 | - | $1.26 B(+30.3%) |
| June 1997 | - | $971.00 M(+1.0%) |
| Mar 1997 | - | $961.00 M(-0.5%) |
| Dec 1996 | $966.00 M(+52.1%) | $966.00 M(+54.3%) |
| Sept 1996 | - | $626.00 M(+9.4%) |
| June 1996 | - | $572.00 M(-8.6%) |
| Mar 1996 | - | $626.00 M(-1.4%) |
| Dec 1995 | $635.00 M(-1.4%) | $635.00 M(+0.5%) |
| Sept 1995 | - | $632.00 M(-6.9%) |
| June 1995 | - | $679.00 M(+2.1%) |
| Mar 1995 | - | $665.00 M(+3.3%) |
| Dec 1994 | $644.00 M(+9.5%) | $644.00 M(+0.8%) |
| Sept 1994 | - | $639.00 M(+0.5%) |
| June 1994 | - | $636.00 M(+1.3%) |
| Mar 1994 | - | $628.00 M(+6.8%) |
| Dec 1993 | $588.00 M(+234.1%) | $588.00 M(-2.6%) |
| Sept 1993 | - | $604.00 M(+0.5%) |
| June 1993 | - | $601.00 M(+233.9%) |
| Mar 1993 | - | $180.00 M(+2.3%) |
| Dec 1992 | $176.00 M(+30.4%) | $176.00 M(+27.5%) |
| Sept 1992 | - | $138.00 M(+60.5%) |
| June 1992 | - | $86.00 M(-34.8%) |
| Mar 1992 | - | $132.00 M(-2.2%) |
| Dec 1991 | $135.00 M(-41.6%) | $135.00 M(-11.8%) |
| Sept 1991 | - | $153.00 M(-7.8%) |
| June 1991 | - | $166.00 M(-23.1%) |
| Mar 1991 | - | $216.00 M(-6.5%) |
| Dec 1990 | $231.00 M(-2.5%) | $231.00 M(-7.2%) |
| Sept 1990 | - | $249.00 M(+9.2%) |
| June 1990 | - | $228.00 M(-1.7%) |
| Mar 1990 | - | $232.00 M(-2.1%) |
| Dec 1989 | $237.00 M(-16.5%) | $237.00 M(-16.5%) |
| Dec 1988 | $284.00 M(+1.8%) | $284.00 M(+1.8%) |
| Dec 1987 | $279.00 M | $279.00 M |
FAQ
- What is Bristol-Myers Squibb annual long term debt?
- What is the all time high annual long term debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual long term debt year-on-year change?
- What is Bristol-Myers Squibb quarterly long term debt?
- What is the all time high quarterly long term debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly long term debt year-on-year change?
What is Bristol-Myers Squibb annual long term debt?
The current annual long term debt of BMY is $38.18 B
What is the all time high annual long term debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual long term debt is $49.17 B
What is Bristol-Myers Squibb annual long term debt year-on-year change?
Over the past year, BMY annual long term debt has changed by +$1.87 B (+5.14%)
What is Bristol-Myers Squibb quarterly long term debt?
The current quarterly long term debt of BMY is $50.16 B
What is the all time high quarterly long term debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly long term debt is $51.05 B
What is Bristol-Myers Squibb quarterly long term debt year-on-year change?
Over the past year, BMY quarterly long term debt has changed by +$16.51 B (+49.05%)